Assessment of New Molecular Imaging Strategies for Prostate Cancer
NCT02813226
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
36
Enrollment
OTHER
Sponsor class
Conditions
Prostate Cancer
Interventions
OTHER:
Molecular Imaging
Sponsor
Ontario Clinical Oncology Group (OCOG)